Alleviation of Liver Dysfunction, Oxidative Stress and Inflammation Underlies the Protective Effect of Ferulic Acid in Methotrexate-Induced Hepatotoxicity

• Published in: Drug design, development and therapy development and therapy, 2020-01, Vol.14, p.1933-1941
• Main Authors: Roghani, Mozhdeh, Kalantari, Heibatullah, Khodayar, Mohammad Javad, Khorsandi, Layasadat, Kalantar, Mojtaba, Goudarzi, Mehdi, Kalantar, Hadi
• Format: Article
• Language: English
• Subjects: Administration, Oral; Animals; Antioxidants (Nutrients); Coumaric Acids - administration & dosage; Coumaric Acids - pharmacology; Dose-Response Relationship, Drug; ferulic acid; Inflammation; Inflammation - drug therapy; Inflammation - metabolism; Injections, Intraperitoneal; Interleukins; Liver; Liver - drug effects; Liver - metabolism; Liver diseases; Liver Diseases - drug therapy; Liver Diseases - metabolism; Male; Methotrexate; Methotrexate - administration & dosage; Methotrexate - antagonists & inhibitors; Methotrexate - pharmacology; Mice; Nitric oxide; Original Research; oxidative damage; Oxidative stress; Oxidative Stress - drug effects; Protective Agents; Structure-Activity Relationship; Superoxides
• ISSN: 1177-8881; 1177-8881
• DOI: 10.2147/DDDT.S237107

In multiple studies, involvement of oxidative stress in the pathogenesis of methotrexate (MTX)-mediated liver damage has been confirmed. Use of many drugs has been examined experimentally in order to prevent or diminish oxidative stress. However, no study has yet examined the effects of ferulic acid (FA) on MTX-induced liver damage. This study aimed at evaluating the effects of FA on protection against liver damage induced by MTX in mice. In this the mice were divided into five groups in a random manner: I) control; II) MTX (20 mg/kg); III and IV) FA (50 and 100 mg/kg) + MTX; and V) FA (100 mg/kg), and we measured serum factors, oxidative stress and inflammatory factors. In the MTX group, accumulation of inflammatory cells, accumulation of red blood cell (RBC), and nuclear pyknosis (NP) were detected in the liver. In line with the histological data, the levels of nitric oxide (NO), malondialdehyde (MDA), interleukin-6 (IL-6), and tumor necrosis factor-α increased (TNF-α), whereas the reduced glutathione (GSH), catalase (CAT), total antioxidant capacity (TAC), superoxide dismutase (SOD), and glutathione peroxidase (GPx) content reduced in the MTX group. However, FA ameliorated these hazardous effects in the antioxidant and anti-inflammatory systems in MTX-treated groups. Based on our findings, oxidative stress impairment and MTX-induced liver damage were ameliorated following FA pretreatment at both histological and biochemical levels. Therefore, FA can be effectively used in abrogation of MTX-induced toxicity.